[Deadly drug interactions].
Kitano
Fumihiro
F
Division of Emergency Medicine, University of Fukui Hospital.
Terasawa
Hidekazu
H
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D004077:Digoxin / Q000009:adverse effects; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D010672:Phenytoin / Q000008:administration & dosage; D011804:Quinolines / Q000009:adverse effects; D013806:Theophylline / Q000009:adverse effects; D014859:Warfarin / Q000009:adverse effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D011804:Quinolines; D014859:Warfarin; D010672:Phenytoin; D004077:Digoxin; D013806:Theophylline; C108475:pitavastatin